Cited in:


This article has been cited by:

  1. 1
    B. K. Rana, A. Dhamija, M. S. Panizzon, K. M. Spoon, T. Vasilopoulos, C. E. Franz, M. D. Grant, K. C. Jacobson, K. Kim, M. J. Lyons, J. M. McCaffery, P. K. Stein, H. Xian, D. T. O'Connor, W. S. Kremen, Imputing Observed Blood Pressure for Antihypertensive Treatment: Impact on Population and Genetic Analyses, American Journal of Hypertension, 2014, 27, 6, 828


  2. 2
    Mohamed M. Salim, Walid M. Ebeid, Nahed El-Enany, Fathalla Belal, Mohamed Walash, Gabor Patonay, Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis, Journal of Separation Science, 2014, 37, 9-10
  3. 3
    Augustine N. Odili, Bolaji Abdullahi, A worldwide yearly survey of new data in adverse drug reactions, 2014,


  4. You have free access to this content4
    Michael A. Weber, Exploring Issues in Difficult-to-Treat Hypertension, The Journal of Clinical Hypertension, 2013, 15, 12